Natural killer T cell-based cancer immunotherapy
Clin Cancer Res
.
2006 Oct 15;12(20 Pt 1):5921-3.
doi: 10.1158/1078-0432.CCR-06-1392.
Authors
Hans J J van der Vliet
1
,
Steven P Balk
,
Mark A Exley
Affiliation
1
Cancer Biology Program, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA.
PMID:
17062661
DOI:
10.1158/1078-0432.CCR-06-1392
No abstract available
Publication types
Comment
MeSH terms
Clinical Trials, Phase I as Topic
Humans
Immunotherapy / methods*
Killer Cells, Natural / immunology*
Lymphocyte Transfusion* / adverse effects
Neoplasms / therapy*